SECRETED BETA-AMYLOID PRECURSOR PROTEIN COUNTERACTS THE PROAPOPTOTIC ACTION OF MUTANT PRESENILIN-1 BY ACTIVATION OF NF-KAPPA-B AND STABILIZATION OF CALCIUM HOMEOSTASIS
Q. Guo et al., SECRETED BETA-AMYLOID PRECURSOR PROTEIN COUNTERACTS THE PROAPOPTOTIC ACTION OF MUTANT PRESENILIN-1 BY ACTIVATION OF NF-KAPPA-B AND STABILIZATION OF CALCIUM HOMEOSTASIS, The Journal of biological chemistry, 273(20), 1998, pp. 12341-12351
Mutations in the presenilin-1 (PS-1) gene account for approximately 50
% of the cases of autosomal dominant, early onset, inherited forms of
Alzheimer's disease (AD), PS-1 is an integral membrane protein express
ed in neurons and is localized primarily in the endoplasmic reticulum
(ER), PS-1 mutations may promote neuronal degeneration by altering the
processing of the beta-amyloid precursor protein (APP) and/or by enga
ging apoptotic pathways. Alternative processing of APP in AD may incre
ase production of neurotoxic amyloid beta-peptide (AP) and reduce prod
uction of the neuroprotective alpha-secretase-derived form of APP (sAP
P alpha). In differentiated PC12 cells expressing an AD-linked PS-1 mu
tation (L286V), sAPP alpha activated the transcription factor NF-kappa
B and prevented apoptosis induced by A beta. Treatment of cells with
K beta decoy DNA blocked the antiapoptotic action of sAPP alpha, demon
strating the requirement for NF-kappa B activation in the cytoprotecti
ve action of sAPP alpha. Cells expressing mutant PS-1 exhibited an abe
rrant pattern of NF-kappa B activity following exposure to A beta, whi
ch was characterized by enhanced early activation of NF-kappa B follow
ed by a prolonged depression of activity. Blockade of NF-kappa B activ
ity in cells expressing mutant PS-1 by kappa B decoy DNA was associate
d with enhanced A beta-induced increases of [Ca2+](i) and mitochondria
l dysfunction. Treatment of cells with sAPP alpha stabilized [Ca2+](i)
and mitochondrial function and suppressed oxidative stress by a mecha
nism involving activation of NF-kappa B. Blockade of ER calcium releas
e prevented (and stimulation of ER calcium release by thapsigarin indu
ced) apoptosis in cells expressing mutant PS-1, suggesting a pivotal r
ole for ER calcium release in the proapoptotic action of mutant PS-1.
Finally, a role for NF-kappa B in preventing apoptosis induced by ER c
alcium release was demonstrated by data showing that sAPP alpha preven
ts thapsigargin-induced apoptosis, an effect blocked by kappa B decoy
DNA. We conclude that sAPP alpha stabilizes cellular calcium homeostas
is and protects neural cells against the proapoptotic action of mutant
PS-1 by a mechanism involving activation of NF-kappa B. The data furt
her suggest that PS-1 mutations result in aberrant NF-kappa B regulati
on that may render neurons vulnerable to apoptosis.